Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Betahistine mesylate
Cat. No.:
OB0225LY-0150
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR.
Size:
Product Overview
Description:
Betahistine mesylate is a histamine analog and H1 receptor agonist.
Synonym:
Extovyl; Melopat; Meginalisk; 54856-23-4; Riptonin; 2-Pyridineethanamine, N-methyl-, dimethanesulfonate; N-Methyl-2-(2-pyridinyl)ethanamine methanesulfonate; N-Methyl-2-pyridin-2-ylethylamine dimethanesulfonate; N-Methyl-2-(pyridin-2-yl)ethanamine dimethanesulfonate
CAS No.:
54856-23-4
Compound CID:
198334
Formula:
C8H12N2·2(CH4O3S)
Formula Weight:
328.4
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Betahistine mesylate can be used to improve microcirculation in the inner ear, aiming to reduce symptoms such as vertigo and tinnitus.
Library Information
Targets:
Histamine receptor
Receptors:
H1 receptor; H3 receptor
Pathways:
GPCR/G protein; Neuronal signaling; Immunology/Inflammation
Plate Number:
AOCL-2
Plate Location:
h3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
59 mg/mL; 179.7 mM
